Prenetics Global (PRE) Beginning Cash Balance (2022 - 2023)
Prenetics Global's (PRE) quarterly Beginning Cash Balance came in at $922142.0 in Q4 2023, down 84.42% year-over-year from $5.9 million in Q4 2022, and down 84.42% quarter-over-quarter from $5.9 million in Q4 2022.
Powered by 
Analysis
Prenetics Global (PRE) Beginning Cash Balance (2022 - 2023) Analysis & Trends
Prenetics Global (PRE) has reported Beginning Cash Balance for 2 consecutive years, with $922142.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Beginning Cash Balance fell 84.42% year-over-year to $922142.0 in Q4 2023; TTM through Dec 2023 was $922142.0, a 84.42% decrease from a year earlier, with the FY2023 full-year figure at $922142.0, down 84.42% from the prior year.
- Beginning Cash Balance was $922142.0 for Q4 2023 at Prenetics Global, down from $5.9 million in the prior quarter.
- Over five years, Beginning Cash Balance peaked at $5.9 million in Q4 2022 and troughed at $922142.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |